Stephen From
President and Chief Executive Officer
Pharmaceutical
Eyegate Pharmaceuticals Inc
United States of America
Biography
Stephen has filled in as our President, Chief Executive Officer, and chief since October 2005. Before joining EyeGate, he was the Chief Financial Officer at Centelion SAS, a free biotechnology auxiliary of Sanofi-Aventis. Beforehand, Mr. From put in quite a long while as a speculation investor represent considerable authority in the biotechnology and medicinal gadget parts as Director in the Global Healthcare Corporate and Investment Banking Group and Head of European Life Sciences for Bank of America Securities. Mr. From holds a BSc from the University of Western Ontario, a bookkeeping certificate from Wilfred Laurier University and has qualified as a Chartered Accountant in Ontario, Canada.
Research Interest
Iontophoresis Delivery System